Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

A

ALNY

Alnylam Pharmaceuticals Inc

224.61

Aug 18 • 4:00 AM ET +0.01 (0.00%)

Healthcare Biotechnology USA Large NASD

Peers: ARGX REGN VRTX BMRN ONC BIIB AMGN GILD ABBV LLY

| Held by: VTI VO QQQ VUG VXF VOT IBB IWP TCAF CGGR

Scroll to Statements

Index	NDX
Market Cap	30.05B
Enterprise Value	29.73B
Income	807.99M
Sales	4.80B
Book/sh	10.13
Cash/sh	24.72
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2500
IPO	May 28, 2004

P/E	37.92
Forward P/E	22.13
PEG	0.29
P/S	6.26
P/B	22.18
P/C	9.09
P/FCF	37.85
EV/EBITDA	28.20
EV/Sales	6.19
Quick Ratio	2.99
Current Ratio	3.05
Debt/Eq	2.21
LT Debt/Eq	1.98
Option/Short	Yes / Yes

EPS (ttm)	5.92
EPS next Y	10.15
EPS next Q	1.77
EPS this Y	188.34%
EPS next Y	51.07%
EPS next 5Y	75.75%
EPS past 3/5Y	- -
Sales past 3/5Y	52.98% 49.77%
EPS Y/Y TTM	347.31%
Sales Y/Y TTM	95.14%
EPS Q/Q	337.86%
Sales Q/Q	66.86%
Earnings	Jul 30 BMO
EPS/Sales Surpr.	-25.78% -2.36%

Insider Own	0.41%
Insider Trans	-7.33%
Inst Own	100.68%
Inst Trans	-1.36%
ROA	15.96%
ROE	100.70%
ROIC	20.01%
Gross Margin	79.65%
Oper. Margin	20.81%
Profit Margin	16.82%
SMA20	-5.28%
SMA50	-16.82%
SMA200	-32.78%
Trades

Shs Outstand	133.73M
Shs Float	133.37M
Short Float	3.60%
Short Ratio	2.95
Short Interest	4.80M
52W High	495.55 -54.67%
52W Low	197.81 13.55%
Volatility	2.92% 4.39%
ATR (14)	11.65
RSI (14)	38.52
Beta	0.29
Rel Volume	0.00
Avg Volume	1.63M
Volume	145

Perf Week	1.54%
Perf Month	-17.63%
Perf Quarter	-21.54%
Perf Half Y	-32.47%
Perf YTD	-43.52%
Perf Year	-50.84%
Perf 3Y	20.74%
Perf 5Y	13.71%
Perf 10Y	205.84%
Recom	1.58
Target Price	375.34
Prev Close	224.60
Price	224.61
Change %	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)